Cargando…

Monogenec Arrhythmic Syndromes: From Molecular and Genetic Aspects to Bedside

The abrupt cessation of effective cardiac function that is generally due to heart rhythm disorders can cause sudden and unexpected death at any age and is referred to as a syndrome called “sudden cardiac death” (SCD). Annually, about 400,000 cases of SCD occur in the United States alone. Less than 5...

Descripción completa

Detalles Bibliográficos
Autores principales: E.Z., Golukhova, O.I., Gromova, R.A., Shomahov, N.I., Bulaeva, L.A., Bockeria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: A.I. Gordeyev 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947989/
https://www.ncbi.nlm.nih.gov/pubmed/27437140
_version_ 1782443264965607424
author E.Z., Golukhova
O.I., Gromova
R.A., Shomahov
N.I., Bulaeva
L.A., Bockeria
author_facet E.Z., Golukhova
O.I., Gromova
R.A., Shomahov
N.I., Bulaeva
L.A., Bockeria
author_sort E.Z., Golukhova
collection PubMed
description The abrupt cessation of effective cardiac function that is generally due to heart rhythm disorders can cause sudden and unexpected death at any age and is referred to as a syndrome called “sudden cardiac death” (SCD). Annually, about 400,000 cases of SCD occur in the United States alone. Less than 5% of the resuscitation techniques are effective. The prevalence of SCD in a population rises with age according to the prevalence of coronary artery disease, which is the most common cause of sudden cardiac arrest. However, there is a peak in SCD incidence for the age below 5 years, which is equal to 17 cases per 100,000 of the population. This peak is due to congenital monogenic arrhythmic canalopathies. Despite their relative rarity, these cases are obviously the most tragic. The immediate causes, or mechanisms, of SCD are comprehensive. Generally, it is arrhythmic death due to ventricular tachyarrythmias – sustained ventricular tachycardia (VT) or ventricular fibrillation (VF). Bradyarrhythmias and pulseless electrical activity account for no more than 40% of all registered cardiac arrests, and they are more often the outcome of the abovementioned arrhythmias. Our current understanding of the mechanisms responsible for SCD has emerged from decades of basic science investigation into the normal electrophysiology of the heart, the molecular physiology of cardiac ion channels, the fundamental cellular and tissue events associated with cardiac arrhythmias, and the molecular genetics of monogenic disorders of the heart rhythm (for example, the long QT syndrome). This review presents an overview of the molecular and genetic basis of SCD in the long QT syndrome, Brugada syndrome, short QT syndrome, catecholaminergic polymorphic ventricular tachycardia and idiopathic ventricular fibrillation, and arrhythmogenic right ventricular dysplasia, and sudden cardiac death prevention strategies by modern techniques (including implantable cardioverter-defibrillator)
format Online
Article
Text
id pubmed-4947989
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher A.I. Gordeyev
record_format MEDLINE/PubMed
spelling pubmed-49479892016-07-19 Monogenec Arrhythmic Syndromes: From Molecular and Genetic Aspects to Bedside E.Z., Golukhova O.I., Gromova R.A., Shomahov N.I., Bulaeva L.A., Bockeria Acta Naturae Research Article The abrupt cessation of effective cardiac function that is generally due to heart rhythm disorders can cause sudden and unexpected death at any age and is referred to as a syndrome called “sudden cardiac death” (SCD). Annually, about 400,000 cases of SCD occur in the United States alone. Less than 5% of the resuscitation techniques are effective. The prevalence of SCD in a population rises with age according to the prevalence of coronary artery disease, which is the most common cause of sudden cardiac arrest. However, there is a peak in SCD incidence for the age below 5 years, which is equal to 17 cases per 100,000 of the population. This peak is due to congenital monogenic arrhythmic canalopathies. Despite their relative rarity, these cases are obviously the most tragic. The immediate causes, or mechanisms, of SCD are comprehensive. Generally, it is arrhythmic death due to ventricular tachyarrythmias – sustained ventricular tachycardia (VT) or ventricular fibrillation (VF). Bradyarrhythmias and pulseless electrical activity account for no more than 40% of all registered cardiac arrests, and they are more often the outcome of the abovementioned arrhythmias. Our current understanding of the mechanisms responsible for SCD has emerged from decades of basic science investigation into the normal electrophysiology of the heart, the molecular physiology of cardiac ion channels, the fundamental cellular and tissue events associated with cardiac arrhythmias, and the molecular genetics of monogenic disorders of the heart rhythm (for example, the long QT syndrome). This review presents an overview of the molecular and genetic basis of SCD in the long QT syndrome, Brugada syndrome, short QT syndrome, catecholaminergic polymorphic ventricular tachycardia and idiopathic ventricular fibrillation, and arrhythmogenic right ventricular dysplasia, and sudden cardiac death prevention strategies by modern techniques (including implantable cardioverter-defibrillator) A.I. Gordeyev 2016 /pmc/articles/PMC4947989/ /pubmed/27437140 Text en Copyright ® 2016 Park-media Ltd. http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
E.Z., Golukhova
O.I., Gromova
R.A., Shomahov
N.I., Bulaeva
L.A., Bockeria
Monogenec Arrhythmic Syndromes: From Molecular and Genetic Aspects to Bedside
title Monogenec Arrhythmic Syndromes: From Molecular and Genetic Aspects to Bedside
title_full Monogenec Arrhythmic Syndromes: From Molecular and Genetic Aspects to Bedside
title_fullStr Monogenec Arrhythmic Syndromes: From Molecular and Genetic Aspects to Bedside
title_full_unstemmed Monogenec Arrhythmic Syndromes: From Molecular and Genetic Aspects to Bedside
title_short Monogenec Arrhythmic Syndromes: From Molecular and Genetic Aspects to Bedside
title_sort monogenec arrhythmic syndromes: from molecular and genetic aspects to bedside
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947989/
https://www.ncbi.nlm.nih.gov/pubmed/27437140
work_keys_str_mv AT ezgolukhova monogenecarrhythmicsyndromesfrommolecularandgeneticaspectstobedside
AT oigromova monogenecarrhythmicsyndromesfrommolecularandgeneticaspectstobedside
AT rashomahov monogenecarrhythmicsyndromesfrommolecularandgeneticaspectstobedside
AT nibulaeva monogenecarrhythmicsyndromesfrommolecularandgeneticaspectstobedside
AT labockeria monogenecarrhythmicsyndromesfrommolecularandgeneticaspectstobedside